The remediation effects of working memory training in schizophrenia patients with prominent negative symptoms

被引:6
|
作者
Li, Xu [1 ,2 ,3 ]
Chu, Min-yi [4 ]
Lv, Qin-yu [5 ]
Hu, Hui-xin [4 ]
Li, Zhi [1 ,2 ]
Yi, Zheng-hui [5 ]
Wang, Jin-hong [6 ]
Zhang, Jian-ye [6 ]
Lui, Simon S. Y. [1 ,7 ]
Cheung, Eric F. C. [7 ]
Shum, David H. K. [1 ,8 ,9 ,10 ]
Chan, Raymond C. K. [1 ,2 ,4 ,8 ,9 ]
机构
[1] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing, Peoples R China
[2] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China
[3] Cent China Normal Univ, Sch Psychol, Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Hubei, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Translat Neuropsychol & Appl Cognit Neurosci Lab, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
[6] Shanghai Mental Hlth Ctr, MRI Ctr, Shanghai, Peoples R China
[7] Castle Peak Hosp, Hong Kong, Peoples R China
[8] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia
[9] Griffith Univ, Sch Appl Psychol, Gold Coast, Australia
[10] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Peoples R China
基金
中国国家自然科学基金;
关键词
Dual n-back training; hedonic processing; anticipatory pleasure; consummatory pleasure; functional magnetic resonance imaging (fMRI); COGNITIVE REMEDIATION; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; METAANALYSIS; SCALE; ANHEDONIA; PLEASURE; DEFICITS; TASK; ABNORMALITIES;
D O I
10.1080/13546805.2019.1674644
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Negative symptoms, particularly amotivation and anhedonia, are important predictors of poor functional outcome in patients with schizophrenia. There has been interest in the efficacy and mechanism of non-pharmacological interventions to alleviate these symptoms. The present study aimed to examine the remediation effect of working memory (WM) training in patients with schizophrenia with prominent negative symptoms. Methods: Thirty-one schizophrenia patients with prominent negative symptoms were recruited and assigned to either a WM training group or a treatment-as-usual (TAU) control group. The WM training group underwent 20 sessions of training using the dual n-back task over one month. A functional neuroimaging paradigm of the Affective Incentive Delay (AID) task was administered before and after the training intervention to evaluate the remediation effect of the intervention. Results: Our results showed that the WM training group demonstrated significant improvement in the WM training task and inattention symptoms. Compared with the TAU group, increased brain activations were observed at the right insula and the right frontal sub-gyral after WM training in the training group. Conclusions: These findings support the efficacy of WM training in ameliorating hedonic dysfunction in schizophrenia patients with prominent negative symptoms.
引用
收藏
页码:434 / 453
页数:20
相关论文
共 50 条
  • [41] VASOPRESSIN (DDAVP) THERAPY IN CHRONIC-SCHIZOPHRENIA - EFFECTS ON NEGATIVE SYMPTOMS AND MEMORY
    BRAMBILLA, F
    BONDIOLOTTI, GP
    MAGGIONI, M
    SCIASCIA, A
    GRILLO, W
    SANNA, F
    LATINA, A
    PICOTTI, GB
    NEUROPSYCHOBIOLOGY, 1988, 20 (03) : 113 - 119
  • [42] Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
    Marc Krause
    Yikang Zhu
    Maximilian Huhn
    Johannes Schneider-Thoma
    Irene Bighelli
    Adriani Nikolakopoulou
    Stefan Leucht
    European Archives of Psychiatry and Clinical Neuroscience, 2018, 268 : 625 - 639
  • [43] Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
    Krause, Marc
    Zhu, Yikang
    Huhn, Maximilian
    Schneider-Thoma, Johannes
    Bighelli, Irene
    Nikolakopoulou, Adriani
    Leucht, Stefan
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2018, 268 (07) : 625 - 639
  • [44] Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
    Stauffer, Virginia L.
    Millen, Brian A.
    Andersen, Scott
    Kinon, Bruce J.
    LaGrandeur, Lisa
    Lindenmayer, J. P.
    Gomez, Juan Carlos
    SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) : 434 - 441
  • [45] Viral metagenomics in drug-naive, first-onset schizophrenia patients with prominent negative symptoms
    Canuti, Marta
    van Beveren, Nico J. M.
    Farsani, Seyed Mohammad Jazaeri
    de Vries, Michel
    Deijs, Martin
    Jebbink, Maarten F.
    Zaaijer, Hans L.
    van Schaik, Barbera D. C.
    van Kampen, Antoine H. C.
    van der Kuyl, Antoinette C.
    de Haan, Lieuwe
    Storosum, Jitschak G.
    van der Hoek, Lia
    PSYCHIATRY RESEARCH, 2015, 229 (03) : 678 - 684
  • [46] Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms
    Stauffer, Virginia L.
    Song, Guochen
    Kinon, Bruce J.
    Ascher-Svanum, Haya
    Chen, Lei
    Feldman, Peter D.
    Conley, Robert R.
    SCHIZOPHRENIA RESEARCH, 2012, 134 (2-3) : 195 - 201
  • [47] STRESS EFFECTS ON WORKING MEMORY IN SCHIZOPHRENIA
    Diehl, Caroline
    Lake, Jessica
    Reed, Alexandra
    Cannon, Tyrone
    Green, Michael
    Subotnik, Kenneth
    Ventura, Joseph
    Miller, Gregory
    Nuechterlein, Keith
    Yee, Cindy
    PSYCHOPHYSIOLOGY, 2019, 56 : S91 - S91
  • [48] No Effects of Antidepressants on Negative Symptoms in Schizophrenia
    Hinkelmann, Kim
    Yassouridis, Alexander
    Kellner, Michael
    Jahn, Holger
    Wiedemann, Klaus
    Raedler, Thomas J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (05) : 686 - 690
  • [49] The Effects of Bupropion on Negative Symptoms in Schizophrenia
    Yassini, Mojtaba
    Shariat, Neda
    Nadi, Mohammad
    Amini, Fariba
    Vafaee, Mohammad
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (04): : 1227 - 1233
  • [50] Medication effects on negative symptoms in schizophrenia
    vanKammen, DP
    Kelley, ME
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 243 - 243